HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rebecca Garris Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

3/2014Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rebecca Garris Research Topics

Disease

26Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2022 - 08/2010
23Philadelphia Chromosome
09/2022 - 08/2010
6Pathologic Complete Response
01/2019 - 09/2010
5Residual Neoplasm
02/2018 - 12/2014
3Infections
12/2018 - 11/2015
2Exanthema (Rash)
12/2018 - 11/2015
2Pancreatitis
12/2018 - 11/2015
2Hypertension (High Blood Pressure)
12/2018 - 11/2015
2Myocardial Infarction
12/2018 - 11/2015
2Hemorrhage
12/2018 - 12/2015
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2018 - 06/2015
1Disease Progression
01/2021
1Thrombocytopenia (Thrombopenia)
01/2018
1Neoplasms (Cancer)
10/2017
1Chromosome Aberrations (Chromosome Abnormalities)
03/2017
1Pericardial Effusion
12/2015
1Mucositis
06/2015
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2014
1Blast Crisis (Blast Phase)
03/2014
1Hypotension (Low Blood Pressure)
08/2013
1Fever (Fevers)
08/2013

Drug/Important Bio-Agent (IBA)

10Tyrosine Kinase InhibitorsIBA
09/2022 - 08/2013
10Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 08/2010
7Dasatinib (BMS 354825)FDA Link
05/2022 - 09/2010
7Inotuzumab OzogamicinIBA
01/2022 - 08/2013
5blinatumomabIBA
09/2022 - 10/2018
5ponatinibIBA
05/2022 - 11/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 08/2010
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 08/2010
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 08/2010
4Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 09/2010
4Prednisone (Sone)FDA LinkGeneric
12/2018 - 09/2010
3Transaminases (Aminotransferases)IBA
12/2018 - 12/2015
2Rituximab (Mabthera)FDA Link
01/2021 - 08/2010
2BilirubinIBA
12/2018 - 08/2013
2Methotrexate (Mexate)FDA LinkGeneric
02/2016 - 01/2016
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2016 - 01/2016
2Monoclonal AntibodiesIBA
08/2013 - 08/2010
1ofatumumabFDA Link
01/2021
1CreatinineIBA
12/2018
1nelarabine (506U78)FDA Link
01/2018
1Proteins (Proteins, Gene)FDA Link
10/2017
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2015
1Alanine Transaminase (SGPT)IBA
11/2015
1EverolimusFDA Link
06/2015

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2021 - 08/2010
10Therapeutics
09/2022 - 08/2010
2Salvage Therapy
01/2021 - 01/2020
2Consolidation Chemotherapy
01/2020 - 01/2018
2Stem Cell Transplantation
02/2018 - 01/2016
1Combination Drug Therapy (Combination Chemotherapy)
01/2019